Pravesh Thapa

Pravesh Thapa has a diverse work experience in the biotechnology and pharmaceutical industries. Pravesh is currently working as the Director of Manufacturing at Parse Biosciences since November 2022. Previously, they worked as the Associate Director of Manufacturing at Arranta Bio from July 2021 to September 2022.

Before that, Pravesh had an extensive tenure at Pfizer, where they held multiple roles. Pravesh served as an Operations Manager from November 2020 to August 2021, overseeing a production group and providing coaching and mentoring to the staff. Prior to that, they held the same position from June 2017 to November 2020, demonstrating their capability to drive compliance and safety, as well as lead troubleshooting activities.

Pravesh also worked as an Engineer/Scientist II at Pfizer from February 2014 to June 2017, showcasing their technical expertise in the field. Pravesh started their career at Pfizer as a Contractor from May 2013 to February 2014.

Before joining Pfizer, Pravesh worked at Lonza Biologics as an Assistant Manufacturing Engineer from October 2011 to September 2012. Their responsibilities in this role included cell culture and fermentation, data analysis, deviation investigation, and process tech transfers.

Additionally, Pravesh had a brief internship experience as an MSAT Intern at Lonza from July 2010 to January 2011, further adding to their professional development.

Overall, Pravesh Thapa has gained valuable experience and expertise throughout their work experience, particularly in manufacturing, operations management, and technical roles in the biotechnology and pharmaceutical industries.

Pravesh Thapa earned a Bachelor's Degree in Biotechnology from Northeastern University, which they attended from 2009 to 2012. From 2017 to 2018, they then pursued an Advanced Management Certificate in Business Administration and Management, General at Babson F.W. Olin Graduate School of Business. Recently, Pravesh completed their Master of Business Administration (MBA) program at Babson F.W. Olin Graduate School of Business from 2019 to 2022.